Protagonist Therapeutics's total assets for Q4 2025 were $669.89M, a decrease of -4.53% from the previous quarter. PTGX total liabilities were $55.19M for the fiscal quarter, a -1.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.